The Danish pharma group lost no time in slamming Hims & Hers' move, saying it deplores the plan to "unlawfully mass-market an unapproved, inauthentic, and untested knockoff semaglutide pill." In a statement, it said: "The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety
We adjust, simplify, or remove the therapy entirely
If someone wants to prepare their fridge before their first GLP-1 dose, Snyder says three upgrades matter most: a high-quality protein staple, hydration support and easy-to-digest produce: Protein: Snyder suggests phasing out ultra-processed protein options like bacon, pepperoni and salami, which can be harder to tolerate early on
Maintenance, dietary cause: daily oral tablets, or an injection around twice a year
Adequate awareness of intramuscular injection sites can prevent damaging nerves and blood vessels